Panamera Holdings Corp (PHCI)
1.31
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Panamera Holdings Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 0.025M |
October 31, 2023 | 0.025M |
July 31, 2023 | 0.10M |
April 30, 2023 | |
January 31, 2023 | 0.025M |
October 31, 2022 | 0.025M |
July 31, 2022 | 0.025M |
April 30, 2022 | 0.0167M |
January 31, 2022 | |
October 31, 2021 | |
July 31, 2021 | |
April 30, 2021 | |
January 31, 2021 | |
October 31, 2020 | |
July 31, 2020 | |
April 30, 2020 | |
January 31, 2020 | |
October 31, 2019 | |
July 31, 2019 |
Date | Value |
---|---|
April 30, 2019 | |
January 31, 2019 | |
October 31, 2018 | |
July 31, 2018 | |
April 30, 2018 | |
January 31, 2018 | |
October 31, 2017 | |
July 31, 2017 | |
April 30, 2017 | |
January 31, 2017 | |
October 31, 2016 | |
July 31, 2016 | |
April 30, 2016 | |
January 31, 2016 | |
October 31, 2015 | |
July 31, 2015 | -0.0285M |
April 30, 2015 | 0.0045M |
January 31, 2015 | 0.012M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0167M
Minimum
Apr 2022
0.10M
Maximum
Jul 2023
0.0345M
Average
0.025M
Median
Jan 2023
Revenue (Quarterly) Benchmarks
R1 RCM Inc | 656.80M |
TruBridge Inc | 84.73M |
PetMed Express Inc | 59.57M |
LENZ Therapeutics Inc | -- |
Oruka Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -7.509M |
Total Expenses (Quarterly) | 7.509M |
EPS Diluted (Quarterly) | -0.17 |
Enterprise Value | 59.56M |
Earnings Yield | -28.42% |
Normalized Earnings Yield | -15.46 |